| ￥5800 | |
| Z03848-100 | |
|
|
|
|
|
|
|
|
|
| Species | Human | ||||||
| Protein Construction |
|
||||||
| Purity | > 95% as determined by Bis-Tris PAGE | ||||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||||
| Biological Activity | Measured by its binding ability in a functional ELISA.Test result was comparable to standard batch. | ||||||
| Expression System | HEK293 | ||||||
| Theoretical Molecular Weight | 29.5 kDa | ||||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 30-48 kDa based on Bis-Tris PAGE result. | ||||||
| Formulation | Lyophilized from a 0.22 μm filtered solution in PBS, pH 7.4. | ||||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Immobilized BCMA/TNFRSF17 Trimer, His & Avi, Human, His Tag at 1 μg/ml (100 μl/well) on the plate. Dose response curve for Human BAFF, hFc Tag with the EC50 of 6.0 ng/ml determined by ELISA. »
The purity of BCMA/TNFRSF17 Trimer, His & Avi, Human is greater than 95% as determined by SEC-HPLC. »
BCMA/TNFRSF17 Trimer, His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
Immobilized BCMA/TNFRSF17 Trimer, His & Avi, Human, His Tag at 0.5 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-BCMA Antibody, hFc Tag with the EC50 of 3.4ng/ml determined by ELISA. »
| Target Background | BCMA (B-cell maturation antigen), also called TNFRSF17, is encoded by the TNFRSF17 gene. It acts as a cell surface receptor of the TNF receptor superfamily. BCMA recognizes B-cell activating factor (BAFF). It interacts with the B-cell activating factor TNFSF13B. |
| Synonyms | CD269; TNFRSF17; BCMA; BCM; TNFRSF13A |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
